Opening book details…
Can I read Lecanemab trial in AD brings hope but requires greater clarity on EtoBox?
Lecanemab trial in AD brings hope but requires greater clarity by Madhav Thambisetty; Robert Howard is a Medicine article available to read on EtoBox.
What is Lecanemab trial in AD brings hope but requires greater clarity about?
The phase III Clarity AD clinical trial of lecanemab, an amyloid-targeting antibody, showed a small clinical benefit in people with Alzheimer disease. However, several questions remain regarding the true clinical relevance, safety and accessibility of lecanemab in this patient population.
Who reads Lecanemab trial in AD brings hope but requires greater clarity?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Madhav Thambisetty; Robert Howard
- Publisher
- Springer Science and Business Media LLC
- Published
- 2023
- Language
- EN
- Field
- Medicine (Health Sciences)